Bacterial and human peptidylarginine deiminases: Targets for inhibiting the autoimmune response in rheumatoid arthritis?

Arthritis Research and Therapy

Volumn 12, Issue 3, 2010, Pages

  Mangat, Pamela ^a   Wegner, Natalia ^a   Venables, Patrick J ^a   Potempa, Jan ^b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; PROTEIN ARGININE DEIMINASE; TETRACYCLINE DERIVATIVE; HYDROLASE; PROTEIN-ARGININE DEIMINASE;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; ENZYME ACTIVATION; ENZYME LOCALIZATION; HUMAN; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; AMINO ACID SEQUENCE; ANIMAL; MOLECULAR GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR;

AMINO ACID SEQUENCE; ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; HUMANS; HYDROLASES; MOLECULAR SEQUENCE DATA; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RISK FACTORS;

EID: 78650553596     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3000     Document Type: Article

References (74)

1. Wegner N, Lundberg K, Kinloch A, Fisher B, Malmström V, Feldmann M, Venables PJ. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2010, 233:34-54. 10.1111/j.0105-2896.2009.00850.x, 20192991.
2. Schellekens GA, Visser H, de Jong BA, Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000, 43:155-163. 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3, 10643712.
3. Chavanas S, Mechin MC, Takahara H, Kawada A, Nachat R, Serre G, Simon M. Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6. Gene 2004, 330:19-27. 10.1016/j.gene.2003.12.038, 15087120.
4. McGraw WT, Potempa J, Farley D, Travis J. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun 1999, 67:3248-3256. 116503, 10377098.
5. Vossenaar ER, Smeets TJ, Kraan MC, Raats JM, van Venrooij WJ, Tak PP. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 2004, 50:3485-3494. 10.1002/art.20584, 15529392.
6. Nielen MM, van Schaardenburg D, Reesink HW, Stadt RJ, Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386. 10.1002/art.20018, 14872479.
7. Rosenstein ED, Greenwald RA, Kushner LJ, Weissmann G. Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation 2004, 28:311-318. 10.1007/s10753-004-6641-z, 16245073.
8. Lundberg K, Kinloch A, Fisher BA, Wegner N, Wait R, Charles P, Mikuls TR, Venables PJ. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 2008, 58:3009-3019. 10.1002/art.23936, 18821669.
9. de Pablo P, Chapple IL, Buckley CD, Dietrich T. Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol 2009, 5:218-224. 10.1038/nrrheum.2009.28, 19337286.
10. Borrell LN, Burt BA, Taylor GW. Prevalence and trends in periodontitis in the USA: the [corrected] NHANES, 1988 to 2000. J Dent Res 2005, 84:924-930. 10.1177/154405910508401010, 16183792.
11. de Pablo P, Dietrich T, McAlindon TE. Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol 2008, 35:70-76.
12. Mercado F, Marshall RI, Klestov AC, Bartold PM. Is there a relationship between rheumatoid arthritis and periodontal disease?. J Clin Periodontol 2000, 27:267-272. 10.1034/j.1600-051x.2000.027004267.x, 10783841.
13. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000 2005, 38:135-187. 10.1111/j.1600-0757.2005.00107.x, 15853940.
14. Tatakis DN, Kumar PS. Etiology and pathogenesis of periodontal diseases. Dent Clin North Am 2005, 49:491-516. 10.1016/j.cden.2005.03.001, 15978238.
15. Mikuls TR, Payne JB, Reinhardt RA, Thiele GM, Maziarz E, Cannella AC, Holers VM, Kuhn KA, O'Dell JR. Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. Int Immunopharmacol 2009, 9:38-42. 10.1016/j.intimp.2008.09.008, 2748386, 18848647.
16. Moen K, Brun JG, Madland TM, Tynning T, Jonsson R. Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients. Clin Diagn Lab Immunol 2003, 10:1043-1050. 262434, 14607865.
17. Moen K, Brun JG, Valen M, Skartveit L, Eribe EK, Olsen I, Jonsson R. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol 2006, 24:656-663.
18. Ogrendik M, Kokino S, Ozdemir F, Bird PS, Hamlet S. Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis. MedGenMed 2005, 7:2. 1681585, 16369381.
19. Martinez-Martinez RE, Abud-Mendoza C, Patino-Marin N, Rizo-Rodriguez JC, Little JW, Loyola-Rodriguez JP. Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J Clin Periodontol 2009, 36:1004-1010. 10.1111/j.1600-051X.2009.01496.x, 19929953.
20. Ogrendik M. Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study. Rheumatol Int 2006, 26:1132-1137. 10.1007/s00296-006-0145-0, 16770616.
21. Ogrendik M. Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate. South Med J 2007, 100:135-139.
22. Ogrendik M. Effects of clarithromycin in patients with active rheumatoid arthritis. Curr Med Res Opin 2007, 23:515-522. 10.1185/030079906X167642, 17355733.
23. O'Dell JR, Haire CE, Palmer W, Drymalski W, Wees S, Blakely K, Churchill M, Eckhoff PJ, Weaver A, Doud D, Erikson N, Dietz F, Olson R, Maloley P, Klassen LW, Moore GF. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1997, 40:842-848. 10.1002/art.1780400510, 9153544.
24. Kloppenburg M, Breedveld FC, Terwiel JP, Mallee C, Dijkmans BA. Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum 1994, 37:629-636. 10.1002/art.1780370505, 8185689.
25. Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, Abramson SB. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci USA 1996, 93:14014-14019. 10.1073/pnas.93.24.14014, 19486, 8943052.
26. Greenwald RA, Golub LM, Lavietes B, Ramamurthy NS, Gruber B, Laskin RS, McNamara TF. Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J Rheumatol 1987, 14:28-32.
27. Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, Friedlander RM. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 2000, 6:797-801. 10.1038/80538, 10888929.
28. Knuckley B, Luo Y, Thompson PR. Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors. Bioorg Med Chem 2008, 16:739-745. 10.1016/j.bmc.2007.10.021, 2267747, 17964793.
29. Imamura T, Matsushita K, Travis J, Potempa J. Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues. Antimicrob Agents Chemother 2001, 45:2871-2876. 10.1128/AAC.45.10.2871-2876.2001, 90745, 11557483.
30. Jang B, Kim E, Choi JK, Jin JK, Kim JI, Ishigami A, Maruyama N, Carp RI, Kim YS, Choi EK. Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis. Am J Pathol 2008, 173:1129-1142. 10.2353/ajpath.2008.080388, 2543080, 18787103.
31. Gyorgy B, Toth E, Tarcsa E, Falus A, Buzas EI. Citrullination: a posttranslational modification in health and disease. Int J Biochem Cell Biol 2006, 38:1662-1677. 10.1016/j.biocel.2006.03.008, 16730216.
32. Young DS, Meersman F, Oxley D, Webster J, Gill AC, Bronstein I, Lowe CR, Dear DV. Effect of enzymatic deimination on the conformation of recombinant prion protein. Biochim Biophys Acta 2009, 1794:1123-1133.
33. Neeli I, Dwivedi N, Khan S, Radic M. Regulation of extracellular chromatin release from neutrophils. J Innate Immun 2009, 1:194-201. 10.1159/000206974, 20375577.
34. Wang Y, Li M, Stadler S, Correll S, Li P, Wang D, Hayama R, Leonelli L, Han H, Grigoryev SA, Allis CD, Coonrod SA. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 2009, 184:205-213. 10.1083/jcb.200806072, 2654299, 19153223.
35. Tanikawa C, Ueda K, Nakagawa H, Yoshida N, Nakamura Y, Matsuda K. Regulation of protein Citrullination through p53/PADI4 network in DNA damage response. Cancer Res 2009, 69:8761-8769. 10.1158/0008-5472.CAN-09-2280, 19843866.
36. Neeli I, Khan SN, Radic M. Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol 2008, 180:1895-1902.
37. Proost P, Loos T, Mortier A, Schutyser E, Gouwy M, Noppen S, Dillen C, Ronsse I, Conings R, Struyf S, Opdenakker G, Maudgal PC, Van Damme J. Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J Exp Med 2008, 205:2085-2097. 10.1084/jem.20080305, 2526203, 18710930.
38. Loos T, Mortier A, Gouwy M, Ronsse I, Put W, Lenaerts JP, Van Damme J, Proost P. Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation. Blood 2008, 112:2648-2656. 10.1182/blood-2008-04-149039, 18645041.
39. Okumura N, Haneishi A, Terasawa F. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin. Clin Chim Acta 2009, 401:119-123. 10.1016/j.cca.2008.12.002, 19109936.
40. Chang X, Yamada R, Sawada T, Suzuki A, Kochi Y, Yamamoto K. The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 2005, 44:293-298. 10.1093/rheumatology/keh473, 15561738.
41. Chapuy-Regaud S, Sebbag M, Baeten D, Clavel C, Foulquier C, De Keyser F, Serre G. Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides. J Immunol 2005, 174:5057-5064.
42. Suzuki A, Yamada R, Yamamoto K. Citrullination by peptidylarginine deiminase in rheumatoid arthritis. Ann N Y Acad Sci 2007, 1108:323-339. 10.1196/annals.1422.034, 17893996.
43. Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, Nagasaki M, Nakayama-Hamada M, Kawaida R, Ono M, Ohtsuki M, Furukawa H, Yoshino S, Yukioka M, Tohma S, Matsubara T, Wakitani S, Teshima R, Nishioka Y, Sekine A, Iida A, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003, 34:395-402. 10.1038/ng1206, 12833157.
44. Foulquier C, Sebbag M, Clavel C, Chapuy-Regaud S, Al Badine R, Méchin MC, Vincent C, Nachat R, Yamada M, Takahara H, Simon M, Guerrin M, Serre G. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum 2007, 56:3541-3553. 10.1002/art.22983, 17968929.
45. Vossenaar ER, Radstake TR, Heijden A, van Mansum MA, Dieteren C, de Rooij DJ, Barrera P, Zendman AJ, van Venrooij WJ. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 2004, 63:373-381. 10.1136/ard.2003.012211, 1754951, 15020330.
46. Kinloch A, Lundberg K, Wait R, Wegner N, Lim NH, Zendman AJ, Saxne T, Malmstrom V, Venables PJ. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum 2008, 58:2287-2295. 10.1002/art.23618, 18668562.
47. Mastronardi FG, Wood DD, Mei J, Raijmakers R, Tseveleki V, Dosch HM, Probert L, Casaccia-Bonnefil P, Moscarello MA. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. J Neurosci 2006, 26:11387-11396. 10.1523/JNEUROSCI.3349-06.2006, 17079667.
48. Makrygiannakis D, af Klint E, Lundberg IE, Lofberg R, Ulfgren AK, Klareskog L, Catrina AI. Citrullination is an inflammation-dependent process. Ann Rheum Dis 2006, 65:1219-1222. 10.1136/ard.2005.049403, 1798285, 16540548.
49. Galkin A, Kulakova L, Sarikaya E, Lim K, Howard A, Herzberg O. Structural insight into arginine degradation by arginine deiminase, an antibacterial and parasite drug target. J Biol Chem 2004, 279:14001-14008. 10.1074/jbc.M313410200, 14701825.
50. Shirai H, Mokrab Y, Mizuguchi K. The guanidino-group modifying enzymes: structural basis for their diversity and commonality. Proteins 2006, 64:1010-1023. 10.1002/prot.20863, 16779844.
51. Arita K, Hashimoto H, Shimizu T, Nakashima K, Yamada M, Sato M. Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol 2004, 11:777-783. 10.1038/nsmb799, 15247907.
52. Rodriguez SB, Stitt BL, Ash DE. Expression of peptidylarginine deiminase from Porphyromonas gingivalis in Escherichia coli: enzyme purification and characterization. Arch Biochem Biophys 2009, 488:14-22. 10.1016/j.abb.2009.06.010, 19545534.
53. Lourbakos A, Chinni C, Thompson P, Potempa J, Travis J, Mackie EJ, Pike RN. Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett 1998, 435:45-48. 10.1016/S0014-5793(98)01036-9, 9755856.
54. Niederman R, Brunkhorst B, Smith S, Weinreb RN, Ryder MI. Ammonia as a potential mediator of adult human periodontal infection: inhibition of neutrophil function. Arch Oral Biol 1990, 35(Suppl):205S-209S. 10.1016/0003-9969(90)90159-8, 2088228.
55. Belotti D, Rieppi M, Nicoletti MI, Casazza AM, Fojo T, Taraboletti G, Giavazzi R. Paclitaxel (Taxol(R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells. Clin Cancer Res 1996, 2:1725-1730.
56. Pritzker LB, Moscarello MA. A novel microtubule independent effect of paclitaxel: the inhibition of peptidylarginine deiminase from bovine brain. Biochim Biophys Acta 1998, 1388:154-160.
57. Brahn E, Tang C, Banquerigo ML. Regression of collagen-induced arthritis with taxol, a microtubule stabilizer. Arthritis Rheum 1994, 37:839-845. 10.1002/art.1780370611, 7911665.
58. ClinicalTrials.gov: search of: paclitaxel AND rheumatoid: a study using intravenous paxceed to treat patients with rheumatoid arthritis. , http://clinicaltrials.gov/ct2/results?term=paclitaxel+AND+rheumatoid
59. Luo Y, Arita K, Bhatia M, Knuckley B, Lee YH, Stallcup MR, Sato M, Thompson PR. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization. Biochemistry 2006, 45:11727-11736. 10.1021/bi061180d, 1808342, 17002273.
60. Luo Y, Knuckley B, Lee YH, Stallcup MR, Thompson PR. A fluoroacetamidinebased inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation. J Am Chem Soc 2006, 128:1092-1093. 10.1021/ja0576233, 1850713, 16433522.
61. Stone EM, Schaller TH, Bianchi H, Person MD, Fast W. Inactivation of two diverse enzymes in the amidinotransferase superfamily by 2-chloroacetamidine: dimethylargininase and peptidylarginine deiminase. Biochemistry 2005, 44:13744-13752. 10.1021/bi051341y, 16229464.
62. Willis V, Gizinski A, Knuckley B, Banda N, Cordova K, Luo Y, Causey C. Treatment with Cl-amidine, a peptidyl arginine deiminase (PAD) inhibitor significantly reduces collagen-induced arthritis (CIA) [abstract]. Arthritis Rheum 2009, 60(suppl 10):665.
63. Bhattacharya SK, Bhat MB, Takahara H. Modulation of peptidyl arginine deiminase 2 and implication for neurodegeneration. Curr Eye Res 2006, 31:1063-1071. 10.1080/02713680600991437, 17169845.
64. Li L, Li Z, Chen D, Lu X, Feng X, Wright EC, Solberg NO, Dunaway-Mariano D, Mariano PS, Galkin A, Kulakova L, Herzberg O, Green-Church KB, Zhang L. Inactivation of microbial arginine deiminases by L-canavanine. J Am Chem Soc 2008, 130:1918. 10.1021/ja0760877, 18205354.
65. Frey C, Narayanan K, McMillan K, Spack L, Gross SS, Masters BS, Griffith OW. L-thiocitrulline. A stereospecific, heme-binding inhibitor of nitric-oxide synthases. J Biol Chem 1994, 269:26083-26091.
66. Nachat R, Mechin MC, Takahara H, Chavanas S, Charveron M, Serre G, Simon M. Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin. J Invest Dermatol 2005, 124:384-393. 10.1111/j.0022-202X.2004.23568.x, 15675958.
67. Nachat R, Mechin MC, Charveron M, Serre G, Constans J, Simon M. Peptidylarginine deiminase isoforms are differentially expressed in the anagen hair follicles and other human skin appendages. J Invest Dermatol 2005, 125:34-41. 10.1111/j.0022-202X.2005.23763.x, 15982300.
68. Mechin MC, Enji M, Nachat R, Chavanas S, Charveron M, Ishida-Yamamoto A, Serre G, Takahara H, Simon M. The peptidylarginine deiminases expressed in human epidermis differ in their substrate specificities and subcellular locations. Cell Mol Life Sci 2005, 62:1984-1995. 10.1007/s00018-005-5196-y, 16091842.
69. Sambandam T, Belousova M, Accaviti-Loper MA, Blanquicett C, Guercello V, Raijmakers R, Nicholas AP. Increased peptidylarginine deiminase type II in hypoxic astrocytes. Biochem Biophys Res Commun 2004, 325:1324-1329. 10.1016/j.bbrc.2004.10.173, 15555572.
70. Ishigami A, Ohsawa T, Hiratsuka M, Taguchi H, Kobayashi S, Saito Y, Murayama S, Asaga H, Toda T, Kimura N, Maruyama N. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosci Res 2005, 80:120-128. 10.1002/jnr.20431, 15704193.
71. Urano Y, Watanabe K, Sakaki A, Arase S, Watanabe Y, Shigemi F, Takeda K, Akiyama K, Senshu T. Immunohistochemical demonstration of peptidylarginine deiminase in human sweat glands. Am J Dermatopathol 1990, 12:249-255. 10.1097/00000372-199006000-00005, 1693817.
72. Ishigami A, Ohsawa T, Asaga H, Akiyama K, Kuramoto M, Maruyama N. Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin. Arch Biochem Biophys 2002, 407:25-31. 10.1016/S0003-9861(02)00516-7, 12392711.
73. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003, 25:1106-1118. 10.1002/bies.10357, 14579251.
74. Hagiwara T, Nakashima K, Hirano H, Senshu T, Yamada M. Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes. Biochem Biophys Res Commun 2002, 290:979-983. 10.1006/bbrc.2001.6303, 11798170.